Role of simvastatin as an immunomodulator in type 2 diabetes: response to Lopes-Virella et al

Diabetes Care. 2004 Aug;27(8):2093-4. doi: 10.2337/diacare.27.8.2093-a.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adjuvants, Immunologic / therapeutic use*
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / immunology*
  • Humans
  • Hydroxymethylglutaryl CoA Reductases / therapeutic use
  • Simvastatin / therapeutic use*

Substances

  • Adjuvants, Immunologic
  • Simvastatin
  • Hydroxymethylglutaryl CoA Reductases